Bulbospinal muscular atrophy of adult

Bulbospinal muscular atrophy of adult, also known as Kennedy disease or X-linked bulbospinal muscular atrophy (SBMA), is a rare neurodegenerative disorder caused by a trinucleotide (CAG) repeat expansion in the androgen receptor (AR) gene on the X chromosome. This expansion leads to a toxic gain of function in the androgen receptor protein, which primarily damages lower motor neurons in the brainstem (bulbar region) and spinal cord. The disease predominantly affects males, with onset typically occurring in adulthood, usually between the ages of 30 and 50. Key clinical features include progressive proximal muscle weakness and atrophy, muscle cramps, fasciculations (visible muscle twitching), and bulbar symptoms such as difficulty swallowing (dysphagia), speech difficulties (dysarthria), and tongue fasciculations. Because the androgen receptor is involved, patients frequently exhibit signs of androgen insensitivity, including gynecomastia (breast enlargement), testicular atrophy, reduced fertility, and erectile dysfunction. Sensory neuropathy may also be present. Elevated creatine kinase levels are commonly observed in laboratory testing. The disease progresses slowly compared to amyotrophic lateral sclerosis (ALS), and life expectancy is often near normal, though bulbar dysfunction can lead to aspiration pneumonia, which is a significant cause of morbidity. There is currently no cure or disease-modifying treatment for Kennedy disease. Management is supportive and multidisciplinary, including physical therapy to maintain mobility, speech therapy for swallowing and communication difficulties, and monitoring for metabolic complications such as diabetes and hyperlipidemia, which can occur in association with the condition. Genetic counseling is important for affected families. Clinical trials investigating various therapeutic approaches, including androgen-reducing therapies and gene-targeted strategies, have been conducted, though none have yet demonstrated definitive efficacy.

Common questions about Bulbospinal muscular atrophy of adult